Dyne Therapeutics Announces Executive and Director Changes
Ticker: DYN · Form: 8-K · Filed: Dec 23, 2025 · CIK: 1818794
| Field | Detail |
|---|---|
| Company | Dyne Therapeutics, INC. (DYN) |
| Form Type | 8-K |
| Filed Date | Dec 23, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $20.78, $45,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, executive-changes, director-changes
TL;DR
Dyne Therapeutics reshuffled execs and board members on 12/22/25.
AI Summary
Dyne Therapeutics, Inc. announced on December 22, 2025, changes in its executive and director roles. The company filed a Form 8-K detailing the departure of certain officers and directors, the election of new directors, and adjustments to compensatory arrangements for its key executives.
Why It Matters
Changes in leadership and executive compensation can signal shifts in company strategy or financial health, impacting investor confidence and stock performance.
Risk Assessment
Risk Level: low — This filing reports routine corporate governance changes and does not indicate any immediate financial distress or significant operational shifts.
Key Players & Entities
- Dyne Therapeutics, Inc. (company) — Registrant
- December 22, 2025 (date) — Date of earliest event reported
- 1560 Trapelo Road Waltham, Massachusetts 02451 (address) — Principal Executive Offices
FAQ
What specific roles were affected by the executive and director changes?
The filing indicates the departure of certain officers and directors, the election of new directors, and changes to compensatory arrangements for certain officers, but does not specify the exact roles affected in this summary.
When was the earliest event reported in this Form 8-K?
The earliest event reported was on December 22, 2025.
What is Dyne Therapeutics, Inc.'s principal executive office address?
The principal executive offices are located at 1560 Trapelo Road, Waltham, Massachusetts 02451.
What is the Commission File Number for Dyne Therapeutics, Inc.?
The Commission File Number is 001-39509.
What is the IRS Employer Identification Number for Dyne Therapeutics, Inc.?
The IRS Employer Identification Number is 36-4883909.
Filing Stats: 741 words · 3 min read · ~2 pages · Grade level 11.1 · Accepted 2025-12-23 07:35:24
Key Financial Figures
- $0.0001 — nge on which registered Common stock, $0.0001 par value per share DYN Nasdaq Glob
- $20.78 — mon stock at an exercise price equal to $20.78 per share, the closing price of the Com
- $45,000 — ill receive annual cash compensation of $45,000 as a member of the Board, annual equity
Filing Documents
- dyn-20251222.htm (8-K) — 54KB
- 0001193125-25-329511.txt ( ) — 164KB
- dyn-20251222.xsd (EX-101.SCH) — 30KB
- dyn-20251222_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DYNE THERAPEUTICS, INC. Date: December 23, 2025 By: /s/ John G. Cox Name: John G. Cox Title: President and Chief Executive Officer